Loading events...
This event listing is based on historical patterns and may not be officially confirmed. Dates, venue, and details are subject to change. Please verify with the event organizer or official website before making travel arrangements.
Verify on official websiteAn entire session at the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali, Rwanda was devoted to the PURPOSE 1 and PURPOSE 2 studies of the six-monthly injectable PrEP drug lenacapavir, which reflects its importance as a step forward in HIV prevention. Lenacapavir for PrEP has recently received positive decisions by drug regulators in the US and Europe . During the conference, the World Health Organization issued guidelines recommending it .
Wednesday, July 30, 2025
Kigali, Rwanda
An entire session at the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali, Rwanda was devoted to the PURPOSE 1 and PURPOSE 2 studies of the six-monthly injectable PrEP drug lenacapavir, which reflects its importance as a step forward in HIV prevention. Lenacapavir for PrEP has recently received positive decisions by drug regulators in the US and Europe . During the conference, the World Health Organization issued guidelines recommending it .
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions takes place on Wednesday, July 30, 2025 in Kigali. All times are in UTC.
WebMobi provides event registration, ticketing, mobile apps, check-in, and analytics — all with zero platform fees.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox